Hosokawa Micron, AnGes MG Succeed in Creating Composite Nanoparticle Contating NF-Kappa B Decoy Oligodeoxynucleotide.Tokyo, Japan, Oct 5, 2005 - (JCNN JCNN Japan Corporate News Network ) - Hosokawa Micron and AnGes MG jointly announced on October 3 that Hosokawa Micron has succeeded in encapsulating NF-kappa B decoy DECOY. A pond used for the breeding and maintenance of water-fowl. 11 Mod. 74, 130; S. C. 3 Salk. 9; Holt, 14 11 East, 571. oligodeoxynucleotide (NFkB decoy oligo) in a composite nanoparticle.
NFkB decoy oligo is a nucleic acid agent developed by AnGes MG. Using Hosokawa's proprietary PLGA PLGA Poly-Lactic-Co-Glycolic Acid
PLGA Plastic Land Grid Array
PLGA Physically Limited Golfers Association (lactide-co-gycolide) nanoparticles, it can improve the efficiency of drug delivery.
In addition, Hosokawa Micron has begun assessing the pharmacological effect of NFkB decoy oligo-containing nanoparticle on skin diseases including atopic dermatitis and psoriasis.
The two companies expect that this achievement will contribute to further development in protein, genetic and nucleic acid drugs.
Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.